The changing landscape of diabetic kidney disease: New reflections on phenotype, classification, and disease progression to influence future investigative studies and therapeutic trials

Advances in Chronic Kidney Disease

Volumn 21, Issue 3, 2014, Pages 256-259

  Ho, Kevin ^a   McKnight, Amy Jayne ^b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ENZYME INHIBITOR; ANTIDIABETIC AGENT;

ARTERIOSCLEROSIS; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; CREATININE CLEARANCE; DIABETIC NEPHROPATHY; DISEASE CLASSIFICATION; DISEASE COURSE; EDITORIAL; END STAGE RENAL DISEASE; FOCAL GLOMERULOSCLEROSIS; FOLLOW UP; GENETIC POLYMORPHISM; GENETIC RISK; GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION RATE; GLYCEMIC CONTROL; HUMAN; HYALINE DEGENERATION; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; INTENSIVE CARE; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY HYPERTROPHY; KIDNEY INJURY; KIDNEY TUBULE BASEMENT MEMBRANE; KIDNEY TUBULE FUNCTION; LONGITUDINAL STUDY; MACROALBUMINURIA; MICROALBUMINURIA; NEPHROSCLEROSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PERSONALIZED MEDICINE; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PROTEINURIA; SEVERE RENAL IMPAIRMENT; ULTRAFILTRATION; URINARY EXCRETION; VASCULAR LESION; CLASSIFICATION; DIABETIC NEPHROPATHIES; GENETICS;

ANTIHYPERTENSIVE AGENTS; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; HUMANS; HYPOGLYCEMIC AGENTS; PHENOTYPE;

EID: 84899584711     PISSN: 15485595     EISSN: 15485609     Source Type: Journal    
DOI: 10.1053/j.ackd.2014.03.002     Document Type: Editorial

References (24)

1. De Boer I.H., Rue T.C., Hall Y.N., et al. Temporal trends in the prevalence of diabetic kidney disease in the United States. J Am Med Assoc 2011, 305(24):2532-2539.
2. USRDS 2013 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States 2013, U.S. Renal Data System, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD.
3. Marshall S.M. Diabetic nephropathy in type 1 diabetes: has the outlook improved since the 1980's?. Diabetologia 2012, 55:2301-2306.
4. DCCT/EDIC Research Group Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes. N Engl J Med 2011, 365(25):2366-2376.
5. Astrup A.S., Tarnow L., Rossing P., Pietraszek L., Hansen P.R., Parving H.-H. Improved prognosis in type 1 diabetic patients with nephropathy: a prospective follow-up study. Kidney Int 2005, 68:1250-1257.
6. Krolewski A.S., Bonventre J.V. High risk of ESRD in type 1 diabetes: new strategies are needed to retard progressive renal function decline. Semin Nephrol 2012, 32(5):407-414.
7. Forsblom C., Harjutsalo V., Thorn L.M., et al. Competing-risk analysis of ESRD and death among patients with type 1 diabetes and macroalbuminuria. J Am Soc Nephrol 2011, 22:537-544.
8. Rosolowsky E.T., Skupien J., Smiles A.M., et al. Risk for ESRD in type 1 diabetes remains high despite renoprotection. J Am Soc Nephrol 2011, 22:545-553.
9. De Boer I.H., Rue T.C., Cleary P.A., et al. Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria. Arch Intern Med 2011, 171(5):412-420.
10. Halimi J.-M. The emerging concept of chronic kidney disease without clinical proteinuria in diabetic patients. Diabetes Metab 2012, 38:291-297.
11. Molitch M.E., Steffes M., Sun W., et al. Development and progression of renal insufficiency with and without albuminuria in adults with type 1 diabetes in the diabetes control and complications trial and the epidemiology of diabetes interventions and complications study. Diabetes Care 2010, 33(7):1536-1543. Epidemiology of Diabetes Interventions and Complications Study Group.
12. Costacou T., Ellis D., Fried L., Orchard T.J. Sequence of progression of albuminuria and decreased GFR in persons with type 1 diabetes: a cohort study. Am J Kidney Dis 2007, 50(5):721-732.
13. Perkins B.A., Ficociello L.H., Ostrander B.E., et al. Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes. J Am Soc Nephrol 2007, 18:1353-1361.
14. Perkins B.A., Ficociello L.H., Roshan B., Warram J.H., Krolewski A.S. In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria. Kidney Int 2010, 77:57-64.
15. Fioretto P., Caramori M.L., Mauer M. The kidney in diabetes: dynamic pathways of injury and repair. Diabetologia 2008, 51:1347-1355.
16. Kramer H.J., Nguyen Q.D., Curhan G., Hsu C.-Y. Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. J Am Med Assoc 2003, 289(24):3273-3277.
17. Penno G., Solini A., Bonora E., et al. Clinical significance of nonalbuminuric renal impairment in type 2 diabetes. J Hypertens 2011, 29:1802-1809.
18. Retnakaran R., Cull C.A., Thorne K.I., Adler A.I., Holman R.R. Risk factors for renal dysfunction in type 2 diabetes. Diabetes 2006, 55:1832-1839.
19. Gaede P., Tarnow L., Vedel P., Parving H.H., Pedersen O. Remission to normoalbuminuria during multifactorial treatment preserves kidney function in patients with type 2 diabetes and microalbuminuria. Nephrol Dial Transplant 2004, 19:2784-2788.
20. Gambara V., Mecca G., Remuzzi G., Bertani T. Heterogeneous natureof renal lesions in type II diabetes. J Am Soc Nephrol 1993, 3:1458-1466.
21. Sharma S.G., Bomback A., Radhakrishnan J., et al. The modern spectrum of renal biopsy findings in patients with diabetes. Clin J Am Soc Nephrol 2013, 8:1718-1724.
22. Fioretto P., Mauer M., Brocco E., et al. Patterns of renal injury in NIDDM patients with microalbuminuria. Diabetologia 1996, 39:1569-1576.
23. Caramori M.L., Fioretto P., Mauer M. Low glomerular filtration rate in normoalbuminuric type 1 diabetic patients. Diabetes 2003, 52:1036-1040.
24. Tervaert T.W.C., Mooyaart A.L., Amann K., et al. Pathologic classification of diabetic nephropathy. J Am Soc Nephrol 2010, 21:556-563.